Comparison of CD4+ T-cell subset distribution in chronically infected HIV+ patients with various CD4 nadir counts

Microbes and Infection

Volumn 12, Issue 5, 2010, Pages 374-381

  Sakai, Keiko ^a   Gatanaga, Hiroyuki ^a,b   Takata, Hiroshi ^a   Oka, Shinichi ^a,b   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

CD4 subset; HIV 1; Nadir CD4 count

Indexed keywords

LYMPHOCYTE SURFACE MARKER;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77950857426     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.01.013     Document Type: Article

References (48)

1. Masopust D., Vezys V., Marzo A.L., and Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291 (2001) 2413
2. Wu C.Y., Kirman J.R., Rotte M.J., Davey D.F., and Perfetto S.P. Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3 (2002) 852
3. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
4. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22 (2004) 745-763
5. Amyes E., McMichael A.J., and Callan M.F.C. Human CD4+ T cells are predominantly distributed among six phenotypically and functionally distinct subsets. J. Immunol. 175 (2005) 5765-5773
6. Harari A., Vallelian F., and Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 34 (2004) 3525-3533
7. Okada R., Kondo T., Matsuki F., Takata H., and Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int. Immunol. 20 (2008) 1189-1199
8. Appay V., van Lier R.A., Sallusto F., and Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73 (2008) 975-983
9. De Rosa S.C., Herzenberg L.A., Herzenberg L.A., and Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7 (2001) 245-248
10. Appay V., Bosio A., Lokan S., Wiencek Y., Biervert C., Kusters D., Devevre E., Speiser D., Romero P., Rufer N., and Leyvraz S. Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages. J. Immunol. 179 (2007) 7406-7414
11. Sugita K., Hirose T., Rothstein D.M., Donahue C., Schlossman S.F., and Morimoto C. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. J. Immunol. 149 (1992) 3208-3216
12. Fritsch R.D., Shen X., Sims G.P., Hathcock K.S., Hodes R.J., and Lipsky P.E. Stepwise differentiation of CD4 memory t cells defined by expression of CCR7 and CD27. J. Immunol. 175 (2005) 6489-6497
13. Ma C.S., Hodgkin P.D., and Tangye S.G. Automatic generation of lymphocyte heterogeneity: division-dependent changes in the expression of CD27, CCR7 and CD45 by activated human naive CD4+ T cells are independently regulated. Immunol. Cell Biol. 82 (2004) 67-74
14. Lane H.C., Depper J.M., Greene W.C., Whalen G., Waldmann T.A., and Fauci A.S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313 (1985) 79-84
15. Murray H.W., Rubin B.Y., Masur H., and Roberts R.B. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310 (1984) 883-889
16. Epstein J.S., Frederick W.R., Rook A.H., Jackson L., Manischewitz J.F., Mayner R.E., Masur H., Enterline J.C., Djeu J.Y., and Quinnan G.V.J. Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J. Infect. Dis. 152 (1985) 727-733
17. Roos M., Miedema F., Koot M., Tersmette M., Schaasberg W., Coutinho R., and Schellekens P. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J. Infect. Dis. 171 (1995) 531-536
18. Connors M., Kovacs J.A., Krevat S., Gea-Banacloche J.C., Sneller M.C., Flanigan M., Metcalf J.A., Walker R.E., Falloon J., Baseler M., Stevens R., Feuerstein I., Masur H., and Lane H.C. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3 (1997) 533-540
19. Schnittman S.M., Lane H.C., Greenhouse J., Justement J.S., Baseler M., and Fauci A.S. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6058-6062
20. Chou C., Gudeman V., O'Rourke S., Isacescu V., Detels R., Williams G., Mitsuyasu R., and Giorgi J. Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease. J. Acquir. Immune Defic. Syndr. 7 (1994) 665-675
21. Bowen D.L., Lane H.C., and Fauci A.S. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann. Intern. Med. 103 (1985) 704-709
22. Gorochov G., Neumann A.U., Kereveur A., Parizot C., Li T., Katlama C., Karmochkine M., Raguin G., Autran B., and Debre P. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat. Med. 4 (1998) 215-221
23. Linette G.P., Hartzman R.J., Ledbetter J.A., and June C.H. HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. Science 241 (1988) 573-576
24. Clerici M., Stocks N.I., Zajac R.A., Boswell R.N., Lucey D.R., Via C.S., and Shearer G.M. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 84 (1989) 1892-1899
25. Miedema F., Petit A.J., Terpstra F.G., Schattenkerk J.K., de Wolf F., Al B.J., Roos M., Lange J.M., Danner S.A., and Goudsmit J. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Clin. Invest. 82 (1988) 1908-1914
26. Fuller M.J., and Zajac A.J. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170 (2003) 477-486
27. Ghanekar S.A., Stranford S.A., Ong J.C., Walker J.M., Maino V.C., and Levy J.A. Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy. AIDS 15 (2001) 1885-1887
28. Harari A., Petitpierre S., Vallelian F., and Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103 (2004) 966-972
29. Iyasere C., Tilton J.C., Johnson A.J., Younes S., Yassine-Diab B., Sekaly R.-P., Kwok W.W., Migueles S.A., Laborico A.C., Shupert W.L., Hallahan C.W., Davey Jr. R.T., Dybul M., Vogel S., Metcalf J., and Connors M. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77 (2003) 10900-10909
30. McNeil A.C., Shupert W.L., Iyasere C.A., Hallahan C.W., Mican J., Davey R.T., and Connors M. High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13878-13883
31. Oxenius A., Zinkernagel R.M., and Hengartner H. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 9 (1998) 449-457
32. Palmer B.E., Blyveis N., Fontenot A.P., and Wilson C.C. Functional and phenotypic characterization of CD57+ CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J. Immunol. 175 (2005) 8415-8423
33. Palmer B.E., Boritz E., Blyveis N., and Wilson C.C. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4+ T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J. Virol. 76 (2002) 5925-5936
34. Palmer B.E., Boritz E., and Wilson C.C. Effects of sustained HIV-1 plasma viremia on HIV-1 gag-Specific CD4+ T cell maturation and function. J. Immunol. 172 (2004) 3337-3347
35. Pitcher C.J., Quittner C., Peterson D.M., Connors M., Koup R.A., Maino V.C., and Picker L.J. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5 (1999) 518-525
36. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., and Walker B.D. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278 (1997) 1447-1450
37. Wilson J.D.K., Imami N., Watkins A., Gill J., Hay P., Gazzard B., Westby M., and Gotch F.M. Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. J. Infect. Dis. 182 (2000) 792-798
38. Younes S.-A., Yassine-Diab B., Dumont A.R., Boulassel M.-R., Grossman Z., Routy J.-P., and Sekaly R.-P. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J. Exp. Med. 198 (2003) 1909-1922
39. When to start consortium, timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373 (2009) 1352-1363
40. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J. Infect. Dis. 197 (2008) 1133-1144
41. Kitahata M.M., Gange S.J., Abraham A.G., Merriman B., Saag M.S., Justice A.C., Hogg R.S., Deeks S.G., Eron J.J., Brooks J.T., Rourke S.B., Gill M.J., Bosch R.J., Martin J.N., Klein M.B., Jacobson L.P., Rodriguez B., Sterling T.R., Kirk G.D., Napravnik S., Rachlis A.R., Calzavara L.M., Horberg M.A., Silverberg M.J., Gebo K.A., Goedert J.J., Benson C.A., Collier A.C., Van Rompaey S.E., Crane H.M., McKaig R.G., Lau B., Freeman A.M., Moore R.D., and the NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. N. Engl. J. Med. 360 (2009) 1815-1826
42. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., and Douek D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 (2004) 749-759
43. Li Q., Duan L., Estes J.D., Ma Z.-M., Rourke T., Wang Y., Cavan R., Carlis J., Miller C.J., and Haase A.T. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 (2005) 1148-1152
44. Lange C.G., Lederman M.M., Medvik K., Asaad R., Wild M., Kalayjian R., and Valdez H. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS 17 (2003) 2015-2023
45. Lange C.G., Valdez H., Medvik K., Asaad R., and Lederman M.M. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin. Immunol. 102 (2002) 154-161
46. + T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J. Immunol. 173 (2004) 2184-2189
47. Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., and Dandekar S. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77 (2003) 11708-11717
48. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F.A., Yassine-Diab B., Boucher G., Boulassel M.-R., Ghattas G., Brenchley J.M., Schacker T.W., Hill B.J., Douek D.C., Routy J.-P., Haddad E.K., and Sekaly R.-P. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15 (2009) 893-900